Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

88.61
Delayed Data
As of Aug 26
 +0.13 / +0.15%
Today’s Change
82.50
Today|||52-Week Range
190.16
-38.76%
Year-to-Date
PRGO Regular Dividend: PRGO began trading ex-dividend on 08/24/16. A $0.145 dividend will be paid to shareholders of record as of 08/26/16.
Mylan: pen is not mightier
Aug 25 / FT.com - Paid Partner Content
 

Today’s Trading

Previous close88.48
Today’s open88.28
Day’s range87.22 - 89.02
Volume3,146,797
Average volume (3 months)2,910,179
Market cap$12.7B
Dividend yield0.65%
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+36.36%
P/E ratio18.7
Price/Sales3.82
Price/Book1.26

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+0.11+0.14%
VRXValeant Pharmaceutic...-0.26-0.84%
INCYIncyte Corp+0.94+1.17%
BMRNBiomarin Pharmaceuti...+1.25+1.32%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.62
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs